FIELD: pharmaceuticals.
SUBSTANCE: described in the invention is a pharmaceutical composition including fragments of peptidoglycan of the cell wall of gram-negative bacteria, the main components whereof are oligomers of muramyldipeptides D, E, F, G, H with a molecular weight of 2,000 to 4,000 u, built from A, B and C blocks connected via glycosidic bonds, wherein muramylpeptide A is of β-N-acetyl-D-glucosaminyl-(1→4)-N-acetyl-D-muramyl-L-alanyl-D-isoglutamine-meso-diaminopimelic acid, muramylpeptide B is of β-N-acetyl-D-glucosaminyl-(1→4)-N-acetyl-D-muramyl-L-alanyl-D-isoglutamine-meso-diaminopimeloyl-D-alanine and muramylpeptide C constitutes a dimer of muramylpeptide B wherein the bond between the monomer residues of muramylpeptide B is executed by means of a carboxyl group of terminal D-alanine of one residue of B and the ω-amino group of the meso-diaminopimelic acid of another residue of B, wherein the trimeric muramyldipeptides D and E are formed due to the combination of the dimeric block C with the monomeric blocks B and A, respectively, the tetrameric muramylpeptides F and G are formed due to the combination of the dimeric block C with two monomeric blocks B or two monomeric blocks A, respectively, and the tetrameric muramylpeptide H formed due to the combination of the dimeric block C with the monomer blocks A and B. Also proposed is a method for producing the composition, including extraction of bacterial cells by a solution of a detergent at elevated temperature, dispersion of the resulting highly purified peptidoglycan under the impact of powerful ultrasound, followed by treatment with lysozyme.
EFFECT: described composition can be used in immunopharmacology, in particular, for creating supportive therapy agents intended for increasing the natural resistance of the body to infections of various natures.
11 cl, 7 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING PHARMACOLOGICALLY ACCEPTABLE MIXTURE OF SUBSTANCES CONTAINING LOW-MOLECULAR INGREDIENTS OF CELL WALL PEPTIDOGLYCANE OF GRAM-NEGATIVE BACTERIA AND POSSESSING IMMUNOSTIMULATORY ACTIVITY | 2008 |
|
RU2478644C2 |
COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
POLYMER FRAGMENT OF PEPTIDOGLICAN OF GRAM-NEGATIVE BACTERIA CELL WALL, METHOD OF ITS OBTAINING AND ITS APPLICATION AS IMMUNOSTIMULATOR | 2006 |
|
RU2412197C2 |
ADJUVANT, BASED ON LOW-MOLECULAR PEPTIDOGLYCAN OF BACTERIAL CELL WALL | 2013 |
|
RU2563354C2 |
BIODEGRADED GLUCOSAMINE MURAMYL PEPTIDES FOR APOPTOSIS MODULATION | 2004 |
|
RU2363490C2 |
SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
PHARMACEUTICAL COMPOSITION OF PATTERN-RECOGNISING RECEPTOR LIGANDS, METHODS FOR USING IT AS IMMUNOSTIMULANT FOR TREATING INFECTION CAUSED BY BACTERIAL AND VIRAL PATHOGENS, METHOD FOR USING IT AS ADJUVANT OF VACCINES | 2012 |
|
RU2497541C1 |
PHARMACEUTICAL COMPOSITION OF IMMUNOSTIMULATING SUBSTANCES OF MURAMYLPEPTIDE NATURE | 2021 |
|
RU2768484C1 |
METHOD OF TREATING SEPTIC SHOCK AND USING MURAMYL COMPOUNDS | 1992 |
|
RU2139086C1 |
METHOD FOR OBTAINING N-ACETYLGLUCOSAMINYL-N-ACETYLMURAMYL-L-ALANYL-D-GLUTAMIC ACID | 2015 |
|
RU2573991C1 |
Authors
Dates
2022-01-27—Published
2020-09-28—Filed